DK153156C - Fremgangsmaade til fremstilling af et krystallinsk anhydrat af natrium-7-(d-2-hydroxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-5-ylmethyl)-3-cephem-4-carboxylat - Google Patents

Fremgangsmaade til fremstilling af et krystallinsk anhydrat af natrium-7-(d-2-hydroxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-5-ylmethyl)-3-cephem-4-carboxylat

Info

Publication number
DK153156C
DK153156C DK575576A DK575576A DK153156C DK 153156 C DK153156 C DK 153156C DK 575576 A DK575576 A DK 575576A DK 575576 A DK575576 A DK 575576A DK 153156 C DK153156 C DK 153156C
Authority
DK
Denmark
Prior art keywords
crystallinic
phenylacetamido
cephem
anhydrate
tetrazol
Prior art date
Application number
DK575576A
Other languages
Danish (da)
English (en)
Other versions
DK575576A (da
DK153156B (da
Inventor
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK575576A publication Critical patent/DK575576A/da
Priority to DK133984A priority Critical patent/DK157761C/da
Priority to DK134184A priority patent/DK158355C/da
Publication of DK153156B publication Critical patent/DK153156B/da
Application granted granted Critical
Publication of DK153156C publication Critical patent/DK153156C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK575576A 1975-12-22 1976-12-21 Fremgangsmaade til fremstilling af et krystallinsk anhydrat af natrium-7-(d-2-hydroxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-5-ylmethyl)-3-cephem-4-carboxylat DK153156C (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DK133984A DK157761C (da) 1975-12-22 1984-02-29 Fremgangsmaade til fremstilling af det krystallinske anhydrat af natriumcefamandol
DK134184A DK158355C (da) 1975-12-22 1984-02-29 Fremgangsmaade til fremstilling af det krystallinske methanolsolvat af natriumcefamandol

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64292275 1975-12-22
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (3)

Publication Number Publication Date
DK575576A DK575576A (da) 1977-06-23
DK153156B DK153156B (da) 1988-06-20
DK153156C true DK153156C (da) 1989-02-20

Family

ID=24578600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK575576A DK153156C (da) 1975-12-22 1976-12-21 Fremgangsmaade til fremstilling af et krystallinsk anhydrat af natrium-7-(d-2-hydroxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-5-ylmethyl)-3-cephem-4-carboxylat

Country Status (31)

Country Link
US (1) US4054738A (cs)
JP (2) JPS5282714A (cs)
AR (1) AR213300A1 (cs)
AT (2) AT349148B (cs)
AU (1) AU505924B2 (cs)
BE (1) BE849415A (cs)
CA (1) CA1080696A (cs)
CH (1) CH628348A5 (cs)
CS (1) CS195746B2 (cs)
DD (1) DD128727A5 (cs)
DE (1) DE2654647C2 (cs)
DK (1) DK153156C (cs)
FI (1) FI66008C (cs)
FR (3) FR2361898A1 (cs)
GB (1) GB1565854A (cs)
GR (1) GR65891B (cs)
HU (1) HU172474B (cs)
IL (3) IL50977A (cs)
LU (1) LU76435A1 (cs)
MX (1) MX3840E (cs)
NL (1) NL187483C (cs)
NO (1) NO148887C (cs)
NZ (1) NZ182694A (cs)
OA (1) OA05518A (cs)
PH (1) PH12191A (cs)
PL (1) PL102739B1 (cs)
PT (1) PT65955B (cs)
RO (3) RO75964A (cs)
SE (3) SE424730B (cs)
SU (3) SU637087A3 (cs)
ZA (1) ZA766957B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
CA1242699A (en) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone and derivatives thereof
JPH0677411B2 (ja) * 1985-05-03 1994-09-28 株式会社フジクラ 高圧直流送電用電力ケーブル
JPS629495U (cs) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
IL57386A0 (en) 1979-09-30
CA1080696A (en) 1980-07-01
JPS61351B2 (cs) 1986-01-08
SU671732A3 (ru) 1979-06-30
PL102739B1 (pl) 1979-04-30
SU1018585A3 (ru) 1983-05-15
DK575576A (da) 1977-06-23
JPS5282714A (en) 1977-07-11
NO148887B (no) 1983-09-26
ATA948976A (de) 1978-07-15
AR213300A1 (es) 1979-01-15
JPS624393B2 (cs) 1987-01-30
US4054738A (en) 1977-10-18
GR65891B (cs) 1980-12-01
DE2654647A1 (de) 1977-06-30
AU2001376A (en) 1978-06-01
OA05518A (fr) 1981-04-30
FR2351985B1 (cs) 1980-06-27
RO69709A (ro) 1980-04-15
ATA217578A (de) 1978-08-15
IL50977A (en) 1980-02-29
HU172474B (hu) 1978-09-28
AT349148B (de) 1979-03-26
FR2361898A1 (fr) 1978-03-17
FR2351984B1 (cs) 1980-06-27
ZA766957B (en) 1978-06-28
NL7614233A (nl) 1977-06-24
SE424730B (sv) 1982-08-09
FI66008C (fi) 1984-08-10
IL50977A0 (en) 1977-01-31
JPS6183189A (ja) 1986-04-26
SE441096B (sv) 1985-09-09
SE8201702L (sv) 1982-03-17
PH12191A (en) 1978-11-21
PT65955A (en) 1977-01-01
DE2654647C2 (de) 1982-06-24
FR2361898B1 (cs) 1980-03-14
SU637087A3 (ru) 1978-12-05
SE443564B (sv) 1986-03-03
CS195746B2 (en) 1980-02-29
SE7614401L (sv) 1977-06-23
NL187483C (nl) 1991-10-16
NO764222L (cs) 1977-06-23
MX3840E (es) 1981-08-11
CH628348A5 (de) 1982-02-26
LU76435A1 (cs) 1977-06-10
NZ182694A (en) 1978-09-25
AU505924B2 (en) 1979-12-06
NO148887C (no) 1984-01-04
FI763682A (cs) 1977-06-23
PT65955B (en) 1978-06-15
FI66008B (fi) 1984-04-30
FR2351985A1 (fr) 1977-12-16
AT348678B (de) 1979-02-26
GB1565854A (en) 1980-04-23
SE8201701L (sv) 1982-03-17
BE849415A (fr) 1977-06-15
DK153156B (da) 1988-06-20
FR2351984A1 (fr) 1977-12-16
DD128727A5 (de) 1977-12-07
IL57387A0 (en) 1979-09-30
RO75963A (ro) 1981-02-28
NL187483B (nl) 1991-05-16
RO75964A (ro) 1981-02-28

Similar Documents

Publication Publication Date Title
DK491780A (da) Fremgangsmaade til fremstilling af cephalosporansyrederivater
PL201586A1 (pl) Sposob wytwarzania nowych zwiazkow spiro-hydantionowych
PL196505A1 (pl) Sposob wytwarzania nowych zwiazkow aminoalkiloheterocyklicznych
DK247376A (da) Fremgangsmade til fremstilling af lithiumforbindelser
DK157760C (da) Fremgangsmaade til fremstilling af 7-(substitueret)-amino-3-substitueret-thiomethyl-cephemcarboxylsyrer
DK160679A (da) Fremgangsmaade til fremstilling af derivater af 4-desacetyl-vincaleucoblastin-c-3-carboxhydrazid
DK95383D0 (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK520679A (da) Fremgangsmaade til fremstilling af 3-quinolincarboxulsyrederivater
NO147985C (no) Fremgangsmaate for fremstilling av meta-aryloksybenzaldehyder
DK152765C (da) Fremgangsmaade til fremstilling af d-(-)-n-carbamylphenylglycin
DK86283D0 (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK584777A (da) Fremgangsmaade til fremstilling af sterolinforbindelser
DK153156C (da) Fremgangsmaade til fremstilling af et krystallinsk anhydrat af natrium-7-(d-2-hydroxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-5-ylmethyl)-3-cephem-4-carboxylat
PL193183A1 (pl) Sposob wytwarzania nowych pochodnych 11-dezoksy-16-arylo-omega-tetranorprostaglandyny
DK554481A (da) Fremgangsmaade til fremstilling af cephalosporansyrederivater
PL190247A1 (pl) Sposob wytwarzania nowych podstawionych heterocyklicznych n-alkanoloamin
DK232080A (da) Fremgangsmaade til fremstilling af hydroxyaminoeburnanderivater
DK300781A (da) Fremgangsmaade til fremstilling af halogenfenylpyridyllylamin-derivater
DK153485C (da) Analogifremgangsmaade til fremstilling af pyridopyrimidinderivater
PL96241B1 (pl) Sposob wytwarzania 2-/2-podstawionych-4-tiazolilo/-benzimidazoli
DK140172C (da) Fremgangsmaade til fremstilling af 5-androsten-17-on-derivater
DK338576A (da) Fremgangsmade til fremstilling af et salt af alfa-methyl-5-benzoyl-2-thiopheneddikesyre
DK208677A (da) Fremgangsmade til fremstilling af maphthylforbindelser
DK183880A (da) Fremgangsmaade til fremstilling af hydroxyderivater af isopropyrimidin
SE443778B (sv) Forfarande for framstellning av aryletrar av hydroxiaminer

Legal Events

Date Code Title Description
PUP Patent expired